Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @uniQure_NV
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @uniQure_NV
-
Patients that test positive for pre-existing anti-AAV5 antibodies can still benefit from AAV5-based
#genetherapy. Our poster on the topic was recognized as a top scoring abstract at#EAHAD2020. Come by tonight's poster session to learn more! http://ow.ly/Tgkp50yeoNo pic.twitter.com/cauJBrAS9h
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
uniQure will have six presentations at this evening’s
#EAHAD2020 poster session, beginning at 18:30 CET. You can access all six posters now on our website. http://uniqure.com/investors-newsroom/overview.php …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Our symposium “The Comprehensive
#Haemophilia Care Team and#GeneTherapy: Continuing the Patient Focus” begins today at 5:15 CET. If you’re in attendance at#EAHAD2020, join us for a discussion of best communication practices between HCPs and#hemophilia patients.pic.twitter.com/Ukc4LuUEYD
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We’re happy to have a strong presence at this week’s
#EAHAD2020, held here in our backyard in The Hague, the Netherlands. We’ll be delivering seven presentations on#genetherapy for#haemophilia, including an oral presentation on Friday. http://ow.ly/Tqfx50ydxrN#hemophiliapic.twitter.com/eDubOt9LpV
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
At today's quarterly uniQure Town Hall, CEO Matt Kapusta reviewed our 2019 successes and laid out plans for what we expect will be a fantastic year ahead as we advance our
#hemophilia,#huntingtonsdisease, and early-stage#genetherapy programs.pic.twitter.com/4Iz8ceWWqK
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Heading to
#EAHAD2020 in the Netherlands this week? Join us for a symposium to examine, from the patients’ perspective, how#hemophilia patients and HCPs can best communicate in the context of#genetherapy.pic.twitter.com/S2ycg8hBvk
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
uniQure's Sr. Director of HEOR Nick Li participated in a panel discussion on “Analysis of Current Reimbursement Trends and New Developments in Market Access” - including the new paradigm of
#genetherapy - at this week's Patient Registries, Real World Evidence and HEOR Summit.pic.twitter.com/udNrb40QmT
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We're looking for a VP of Global Marketing to join our Commercial team. This exciting new position will be responsible for setting the strategy and leading all marketing efforts for uniQure's commercial and pipeline products. Learn more and join us! https://www.linkedin.com/jobs/view/1703851295/ …pic.twitter.com/yQtAts9byc
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
uniQure has a thriving Co-Op Program, which gives bright local students an integrated learning experience while providing our teams with valuable help in the lab/office! We welcome this semester's co-op crew, incl. students from
@Northeastern,@UMassLowell, and@EndicottCollege.pic.twitter.com/eKiQFzA9iw
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
As gene therapy becomes a reality in
#hemophilia, the need for strong and clear communication becomes critical. At#EAHAD2020, we're sponsoring a symposium to examine, from the patients’ perspective, the ways patients and HCPs can best communicate in the context of#genetherapy.pic.twitter.com/5XKlpdLvj8
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Over pizza and salad, our employees learned about Health Economics and Outcomes Research and its role in understanding the clinical value and economic impact of
#genetherapy, as healthcare prepares for the transformative impact of these potentially curative new treatments.pic.twitter.com/IjAEUa0qMF
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
uniQure is kicking off the JP Morgan Conference with an investor breakfast moderated by
#HCWainwright analyst Debjit Chattopadhyay, where we're discussing our plans to advance our#genetherapy candidates to patients.#JPM20$QUREpic.twitter.com/7ajhIHICKs
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Looking forward to heading west for next week's JP Morgan Healthcare Conference, where we'll be meeting with investors and analysts and discussing our top priorities for 2020 at the year's biggest industry meeting.
#JPM20pic.twitter.com/pa1E1SVm8L
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#uniQure Announces Publication of Preclinical Data for#AMT130 in#Huntington’s Disease Supporting Non-Selective HTT-Lowering Approach: http://uniqure.com/investors-newsroom/press-releases.php …$QURE#HDHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Today we welcomed
#Huntingtonsdisease patient advocate Cheryl Sullivan Staveley, who shared the story of the impact HD has had on her family. As we work on#genetherapy AMT-130, we are inspired to do all that we can to deliver a desperately-needed treatment to those with HD.pic.twitter.com/4uhAesLZ2W
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
uniQure VP of Research Pavlina Konstantinova presented our
#genetherapy clinical trial at today's Lega Italiana Ricerca Huntington meeting, where hundreds of Italian patients, artists, scientists, and HCPs discussed the latest developments in#Huntingtonsdisease treatment.pic.twitter.com/peslk7skpC
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
uniQure EVP Sander van Deventer moderated a discussion on advancements toward AAV
#genetherapy for CNS diseases such as#Huntingtonsdisease and#SCA3 at this week's GTxN - Gene Therapy for Neurological Disorders Summit in Boston.pic.twitter.com/WFvDZEWdE9
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
The presents are wrapped with care for our Yankee Swap at tonight's Holiday Party in Lexington, Mass. Happy Holidays from uniQure!pic.twitter.com/AOaDtXPt7B
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
ICYMI, the recording of the
$QURE investor webcast reviewing the#ASH19 data on our#hemophiliaB#genetherapy is now available. http://ow.ly/BI9850xwkUK pic.twitter.com/R3aToJi9Ei
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Dr. Pipe discussing the functionally curative levels of Factor IX activity seen in the three patients in our Ph. 2b study of EtranaDez (AMT-061), our
#genetherapy for patients with#hemophiliaB, at this morning's investor webcast.$QURE http://uniqure.com/investors-newsroom/overview.php …pic.twitter.com/WPemxSFWnN
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.